| Dr Julie Linden Soto, MD | |
|
1703 N Beckley Ave, Dallas, TX 75203-1007 | |
| (214) 987-2875 | |
| (214) 946-9877 |
| Full Name | Dr Julie Linden Soto |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 13 Years |
| Location | 1703 N Beckley Ave, Dallas, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013209493 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | Q4295 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Tulsa Spine & Specialty Hospital | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tulsa Eye Associates, Inc., A Professional Corporation | 9931274602 | 2 |
News Archive
Heart and cancer doctors will get a smaller fee cut next year from Medicare, the U.S. government program for the elderly, than the Obama administration first sought in a move to shift money to family physicians," Bloomberg reports. Earlier this year, Medicare officials said they would cut 10 percent of payments for the two specialties. Now, they plan on making the reductions over four years, instead.
A study published in the American Journal of Clinical Nutrition found that a choline-deficient diet is associated with increased risk for heart defects during prenatal development. Choline is an essential nutrient required for normal cell activity, healthy brain and nerve function, liver metabolism and transportation of nutrients throughout the body.
Researchers at the Johns Hopkins Malaria Research Institute (JHMRI) have identified, for the first time, the molecular components that enable the malaria-causing parasite Plasmodium to infect the salivary glands of the Anopheles mosquito-a critical and final stage for spreading malaria to humans.
BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.
› Verified 5 days ago
| Entity Name | Tulsa Eye Associates, Inc., A Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740449818 PECOS PAC ID: 9931274602 Enrollment ID: O20080814000192 |
News Archive
Heart and cancer doctors will get a smaller fee cut next year from Medicare, the U.S. government program for the elderly, than the Obama administration first sought in a move to shift money to family physicians," Bloomberg reports. Earlier this year, Medicare officials said they would cut 10 percent of payments for the two specialties. Now, they plan on making the reductions over four years, instead.
A study published in the American Journal of Clinical Nutrition found that a choline-deficient diet is associated with increased risk for heart defects during prenatal development. Choline is an essential nutrient required for normal cell activity, healthy brain and nerve function, liver metabolism and transportation of nutrients throughout the body.
Researchers at the Johns Hopkins Malaria Research Institute (JHMRI) have identified, for the first time, the molecular components that enable the malaria-causing parasite Plasmodium to infect the salivary glands of the Anopheles mosquito-a critical and final stage for spreading malaria to humans.
BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julie Linden Soto, MD 3415 Golden Rd, Tyler, TX 75701-8355 Ph: (903) 526-0444 | Dr Julie Linden Soto, MD 1703 N Beckley Ave, Dallas, TX 75203-1007 Ph: (214) 987-2875 |
News Archive
Heart and cancer doctors will get a smaller fee cut next year from Medicare, the U.S. government program for the elderly, than the Obama administration first sought in a move to shift money to family physicians," Bloomberg reports. Earlier this year, Medicare officials said they would cut 10 percent of payments for the two specialties. Now, they plan on making the reductions over four years, instead.
A study published in the American Journal of Clinical Nutrition found that a choline-deficient diet is associated with increased risk for heart defects during prenatal development. Choline is an essential nutrient required for normal cell activity, healthy brain and nerve function, liver metabolism and transportation of nutrients throughout the body.
Researchers at the Johns Hopkins Malaria Research Institute (JHMRI) have identified, for the first time, the molecular components that enable the malaria-causing parasite Plasmodium to infect the salivary glands of the Anopheles mosquito-a critical and final stage for spreading malaria to humans.
BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.
› Verified 5 days ago
Dr. Joanna Saade, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2020 | |
Miss Vanessa Ortiz-medina, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2020 | |
Dr. Deborah I Friedman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-645-0624 Fax: 214-645-0078 | |
Faisal E Haq, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2801 Lemmon Ave Ste 400, Dallas, TX 75204 Phone: 214-754-0000 Fax: 214-379-1849 | |
Gary Pesicka, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2020 | |
Phillip Alan Tenzel, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75284 Phone: 214-645-2020 |